In-Vitro Diagnostics Market Analysis

Bharatbook  Pleased to announce a new report on “In-Vitro Diagnostics Market Analysis” the market, which stood at US$ 52.4 Billion in 2012, is expected to grow at a CAGR of 7% during 2012-2017.

The global in-vitro diagnostics (IVD) market is going through a very exciting phase, offering immense opportunities for players involved in the business. The market, which on one hand, is struggling to maintain a foothold in the unstable economy of Europe is growing astoundingly at a high double-digit growth rate in emerging economies of India, China, and Brazil.

In their latest research study, “In-Vitro Diagnostics Market Analysis to 2017”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 52.4 Billion in 2012, is expected to grow at a CAGR of 7% during 2012-2017.

In the report, the IVD market has been studied on three distinct levels: Regional, Clinical and Player level. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Further, the market has been divided into eight distinct clinical segments and their current and future outlook to 2017 has been analyzed. Through this, our analysts have conducted a thorough opportunity assessment in various clinical segments and highlighted the clinical segments that offer the maximum opportunity for growth in each region.

Besides, our team has also analyzed the revenue generated from each clinical segment to recognize key segments that offer very high growth rates. The study further delves into the business dynamics of major players in the industry that together form more than 70% of the global IVD market. To provide a thorough understanding of the Company’s business model, Company’s current and historical financials have been analyzed. Also, the Company’s revenue from IVD has been depicted with a further breakup by clinical segment. The study also portrays each Company’s strengths and weaknesses that will help the reader to better position its company vis-à-vis competition.
1. Analyst View
2. Research Methodology
3. In Vitro Diagnostic Market Overview
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. Clinical Segmentation Outlook 2017
(For all clinical segments, the section contains following testing market information)
Market by Region (%), 2012
Market by Players (%), 2012
Testing Market (Billion US$), 2012-2017
4.1 Point-of-Care Diagnostics
4.2 Immunochemistry
4.3 Clinical Chemistry
4.4 Molecular Diagnostics
4.5 Hematology
4.6 Microbiology
4.7 Hemostasis
4.8 Immunohematology
5. Geographical Segmentation Outlook 2017
(For all countries, the section contains following information)
Market by Clinical Segment (%), 2012
In Vitro Diagnostic Market (Billion US$), 2012-2017
Market by Clinical Segment (%), 2017
Key Market Drivers
5.1 America
5.1.1 United States
5.1.2 Canada
5.1.3 Brazil
5.1.4 Mexico
5.2 Europe
5.2.1 Germany
5.2.2 France
5.2.3 Italy
5.2.4 United Kingdom
5.2.5 Spain
5.3 Asia-Pacific
5.3.1 Japan
5.3.2 China
5.3.3 India
6. Industry Trends
6.1 Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
6.2 On the Horizon: Non-Invasive Genetic Tests for Cancer
6.3 Non-Invasive Prenatal Diagnostics Market Witnesses Boom
6.4 Companion Diagnostics Partnerships Gear Up
6.5 Predictive Cancer Diagnostic Test Market Rockets Northwards
6.6 POCT: Expanding Avenues into Multiple Disease Diagnosis
7. Competitive Landscape
(For all players, the section contains following information)
Business Overview
Key Financials
Strengths and Weaknesses
Recent Developments
7.1 Market Share of Top Players
7.2 Key Players
7.2.1 Abbott Laboratories
7.2.2 Alere, Inc.
7.2.3 Becton Dickinson
7.2.4 Bayer HealthCare
7.2.5 Beckman Coulter
7.2.6 Biomerieux
7.2.7 Johnson and Johnson
7.2.8 Life Technologies Corporation
7.2.9 Medtronic, Inc.
7.2.10 Qiagen NV
7.2.11 Roche Holding Ltd
7.2.12 Sysmex Corporation
7.2.13 Siemens HealthCare
7.2.14 Thermo Fisher Scientific
List of Figures:
Figure 3-1: Global – In Vitro Diagnostic Market (Billion US$), 2012-2017
Figure 4-1: Global – In Vitro Diagnostic Market by Clinical Segment (%), 2012
Figure 4-2: Global – Point-of-Care Testing Market by Region (%), 2012
Figure 4-3: Global – Point-of-Care Testing Market by Players (%), 2012

For more information kindly visit : http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/in-vitro-diagnostics-market-analysis-to-2017.html

Related reports: www.bharatbook.com/market-research-report/healthcare.html